Archived Facts

Posts Tagged ‘Clarient’

GE’s healthcare unit plans to buy cancer diagnostic company Clarient Inc. in a cash deal worth about $587 million.

Originally posted here:
GE Healthcare set to acquire Clarient for $587 million …

Incoming search terms:

Related Posts:

GE Healthcare this morning said it plans to acquire clinical cancer-testing company Clarient for around $580 million in an effort to expand GE’s footprint in the molecular cancer-testing and pharmacogenetic-testing markets. …

Read this article:
GE Healthcare's Bid to Acquire Clarient Could Alter Clinical …

Incoming search terms:

Related Posts:

THE DEAL: General Electric Co. said its healthcare unit will buy diagnostics company Clarient Inc. to speed its expansion into cancer diagnostic and therapy selection tools.

Excerpt from:
Summary Box: GE to buy diagnostics firm Clarient

Related Posts:

Clarient receives patent for Mammostrat breast cancer prognostic test
Clarient, Inc. a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that the United States Patent and Trademark Office and the European Patent Office have allowed patents covering the technology behind Clarient Insight Dx Mammostrat, a test designed to aid in the classification of the risk of recurrence of breast cancer …

Read more on News-Medical-Net

Incoming search terms:

Related Posts: